(July 1, 1944, ch. 373, title IV, § 409B, as added Pub. L. 105–78, title VI, § 603(c),Nov. 13, 1997, 111 Stat. 1520; amended Pub. L. 109–482, title I, § 103(b)(8),Jan. 15, 2007, 120 Stat. 3687.)
2007—Subsec. (a). Pub. L. 109–482
, § 103(b)(8)(A), substituted “to carry out this section” for “under subsection (e) of this section”.
Subsec. (e). Pub. L. 109–482
, § 103(b)(8)(B), struck out heading and text of subsec. (e). Text read as follows: “For the purpose of carrying out this section and section
of this title and this subchapter with respect to research focused on Parkinson’s disease, there are authorized to be appropriated up to $100,000,000 for fiscal year 1998, and such sums as may be necessary for each of the fiscal years 1999 and 2000.”
Change of Name
Committee on Commerce of House of Representatives changed to Committee on Energy and Commerce of House of Representatives, and jurisdiction over matters relating to securities and exchanges and insurance generally transferred to Committee on Financial Services of House of Representatives by House Resolution No. 5, One Hundred Seventh Congress, Jan. 3, 2001.
Committee on Labor and Human Resources of Senate changed to Committee on Health, Education, Labor, and Pensions of Senate by Senate Resolution No. 20, One Hundred Sixth Congress, Jan. 19, 1999.
Effective Date of 2007 Amendment
Amendment by Pub. L. 109–482
applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see section 109 ofPub. L. 109–482
, set out as a note under section
of this title.
Pub. L. 108–199
, div. E, title II, § 217,Jan. 23, 2004, 118 Stat. 255
, provided that: “Notwithstanding section 409B(c) of the Public Health Service Act [subsec. (c) of this section] regarding a limitation on the number of such grants, funds appropriated in this Act [div. E of Pub. L. 108–199
, see Tables for classification] and Acts in fiscal years thereafter may be expended by the Director of the National Institutes of Health to award Core Center Grants to encourage the development of innovative multidisciplinary research and provide training concerning Parkinson’s disease. Each center funded under such grants shall be designated as a Morris K. Udall Center for Research on Parkinson’s Disease.”
Similar provisions were contained in Pub. L. 108–7
, div. G, title II, § 218,Feb. 20, 2003, 117 Stat. 326
Finding and Purpose
Section 603(b) ofPub. L. 105–78
“(1) Finding.—Congress finds that to take full advantage of the tremendous potential for finding a cure or effective treatment, the Federal investment in Parkinson’s disease must be expanded, as well as the coordination strengthened among the National Institutes of Health research institutes.
“(2) Purpose.—It is the purpose of this section [enacting this section] to provide for the expansion and coordination of research regarding Parkinson’s disease, and to improve care and assistance for afflicted individuals and their family caregivers.”